BG63779B1 - Производни на хинолин-2(1н)-он, антагонисти на серотонина - Google Patents
Производни на хинолин-2(1н)-он, антагонисти на серотонина Download PDFInfo
- Publication number
- BG63779B1 BG63779B1 BG102316A BG10231698A BG63779B1 BG 63779 B1 BG63779 B1 BG 63779B1 BG 102316 A BG102316 A BG 102316A BG 10231698 A BG10231698 A BG 10231698A BG 63779 B1 BG63779 B1 BG 63779B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- radical
- pyridin
- ethyl
- mmol
- thieno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510815A FR2738822B1 (fr) | 1995-09-15 | 1995-09-15 | Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique |
FR9511083A FR2739100B1 (fr) | 1995-09-21 | 1995-09-21 | Derives de 4-(omega-(4-(4-fluorobenzoyl)piperidin-1-yl)- alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique |
PCT/FR1996/001401 WO1997010238A1 (fr) | 1995-09-15 | 1996-09-12 | Derives de quinolein-2(1h)-one comme antagonistes de la serotonine |
Publications (2)
Publication Number | Publication Date |
---|---|
BG102316A BG102316A (en) | 1999-03-31 |
BG63779B1 true BG63779B1 (bg) | 2002-12-29 |
Family
ID=26232206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102316A BG63779B1 (bg) | 1995-09-15 | 1998-03-11 | Производни на хинолин-2(1н)-он, антагонисти на серотонина |
Country Status (30)
Country | Link |
---|---|
US (1) | US5958924A (no) |
EP (1) | EP0850235B1 (no) |
JP (1) | JP3335362B2 (no) |
KR (1) | KR100422850B1 (no) |
CN (1) | CN1094490C (no) |
AR (1) | AR003996A1 (no) |
AT (1) | ATE187172T1 (no) |
AU (1) | AU715879B2 (no) |
BG (1) | BG63779B1 (no) |
BR (1) | BR9610579A (no) |
CA (1) | CA2228038C (no) |
CO (1) | CO4750663A1 (no) |
CZ (1) | CZ288149B6 (no) |
DE (1) | DE69605430T2 (no) |
DK (1) | DK0850235T3 (no) |
EE (1) | EE04116B1 (no) |
ES (1) | ES2142089T3 (no) |
GR (1) | GR3032618T3 (no) |
HK (1) | HK1014868A1 (no) |
HU (1) | HU222745B1 (no) |
IL (1) | IL123600A (no) |
NO (1) | NO323841B1 (no) |
NZ (1) | NZ318436A (no) |
PL (1) | PL184808B1 (no) |
RU (1) | RU2167874C2 (no) |
SI (1) | SI0850235T1 (no) |
SK (1) | SK282222B6 (no) |
TR (1) | TR199800464T1 (no) |
UA (1) | UA44332C2 (no) |
WO (1) | WO1997010238A1 (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9610579A (pt) * | 1995-09-15 | 1999-07-06 | Sanofi Synthelabo | Derivados de quinolein-2(1H)-ona como antagonistas da serotonina |
FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
FR2797874B1 (fr) * | 1999-08-27 | 2002-03-29 | Adir | Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CA2398388A1 (en) * | 2000-01-20 | 2001-07-26 | Koji Kato | Novel piperidine compound and pharmaceutical thereof |
FR2812548B1 (fr) * | 2000-08-01 | 2002-09-20 | Sanofi Synthelabo | Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale |
GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
FR2909670B1 (fr) * | 2006-12-12 | 2010-07-30 | Sanofi Aventis | Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
PT2203439E (pt) | 2007-09-14 | 2011-02-11 | Ortho Mcneil Janssen Pharm | 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridinil-2'- onas 1',3'-dissubstituídas |
NZ584152A (en) | 2007-09-14 | 2011-11-25 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
BRPI0918055A2 (pt) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato. |
JP5541279B2 (ja) * | 2008-10-02 | 2014-07-09 | 大正製薬株式会社 | 7−ピペリジノアルキル−3,4−ジヒドロキノロン誘導体 |
JP5690277B2 (ja) | 2008-11-28 | 2015-03-25 | ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体 |
NZ596078A (en) | 2009-05-12 | 2013-06-28 | Janssen Pharmaceuticals Inc | 1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
CN102439015B (zh) | 2009-05-12 | 2015-05-13 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途 |
CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
ME03518B (me) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena |
SI3096790T1 (sl) | 2014-01-21 | 2019-11-29 | Janssen Pharmaceutica Nv | Kombinacije, ki vsebujejo pozitivne aleostrične modulatorje ali ortosterične agoniste metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba |
SG10201913587WA (en) | 2016-02-05 | 2020-02-27 | Denali Therapeutics Inc | Inhibitors of receptor-interacting protein kinase 1 |
ES2912295T3 (es) | 2016-12-09 | 2022-05-25 | Denali Therapeutics Inc | Compuestos útiles como inhibidores de RIPK1 |
CN108707109A (zh) * | 2018-08-29 | 2018-10-26 | 常州沃腾化工科技有限公司 | 一种2-甲氧基-4-三氟甲基吡啶-3-磺酰氯的制备方法 |
US11999750B2 (en) | 2022-01-12 | 2024-06-04 | Denali Therapeutics Inc. | Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1278792C (en) * | 1985-05-06 | 1991-01-08 | Joseph P. Yevich | Antipsychotic fused-ring pyridinylpiperazine derivatives |
KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
FR2644786B1 (fr) * | 1989-03-21 | 1993-12-31 | Adir Cie | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
BR9610579A (pt) * | 1995-09-15 | 1999-07-06 | Sanofi Synthelabo | Derivados de quinolein-2(1H)-ona como antagonistas da serotonina |
-
1996
- 1996-09-12 BR BR9610579A patent/BR9610579A/pt not_active Application Discontinuation
- 1996-09-12 SK SK346-98A patent/SK282222B6/sk not_active IP Right Cessation
- 1996-09-12 EE EE9800089A patent/EE04116B1/xx not_active IP Right Cessation
- 1996-09-12 WO PCT/FR1996/001401 patent/WO1997010238A1/fr active IP Right Grant
- 1996-09-12 AU AU69919/96A patent/AU715879B2/en not_active Ceased
- 1996-09-12 PL PL96325467A patent/PL184808B1/pl not_active IP Right Cessation
- 1996-09-12 US US09/011,482 patent/US5958924A/en not_active Expired - Lifetime
- 1996-09-12 CA CA002228038A patent/CA2228038C/en not_active Expired - Fee Related
- 1996-09-12 CO CO96048698A patent/CO4750663A1/es unknown
- 1996-09-12 AR ARP960104322A patent/AR003996A1/es active IP Right Grant
- 1996-09-12 AT AT96931112T patent/ATE187172T1/de active
- 1996-09-12 DE DE69605430T patent/DE69605430T2/de not_active Expired - Lifetime
- 1996-09-12 UA UA98031235A patent/UA44332C2/uk unknown
- 1996-09-12 SI SI9630151T patent/SI0850235T1/xx unknown
- 1996-09-12 HU HU9802940A patent/HU222745B1/hu not_active IP Right Cessation
- 1996-09-12 CZ CZ1998786A patent/CZ288149B6/cs not_active IP Right Cessation
- 1996-09-12 ES ES96931112T patent/ES2142089T3/es not_active Expired - Lifetime
- 1996-09-12 NZ NZ318436A patent/NZ318436A/xx not_active IP Right Cessation
- 1996-09-12 DK DK96931112T patent/DK0850235T3/da active
- 1996-09-12 JP JP51170797A patent/JP3335362B2/ja not_active Expired - Fee Related
- 1996-09-12 EP EP96931112A patent/EP0850235B1/fr not_active Expired - Lifetime
- 1996-09-12 CN CN96198333A patent/CN1094490C/zh not_active Expired - Fee Related
- 1996-09-12 RU RU98106501/04A patent/RU2167874C2/ru not_active IP Right Cessation
- 1996-09-12 TR TR1998/00464T patent/TR199800464T1/xx unknown
- 1996-09-12 KR KR10-1998-0701920A patent/KR100422850B1/ko not_active IP Right Cessation
- 1996-09-12 IL IL12360096A patent/IL123600A/en not_active IP Right Cessation
-
1998
- 1998-03-11 BG BG102316A patent/BG63779B1/bg unknown
- 1998-03-13 NO NO19981141A patent/NO323841B1/no not_active IP Right Cessation
- 1998-12-30 HK HK98119241A patent/HK1014868A1/xx not_active IP Right Cessation
-
2000
- 2000-02-09 GR GR20000400317T patent/GR3032618T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG63779B1 (bg) | Производни на хинолин-2(1н)-он, антагонисти на серотонина | |
FI92697C (fi) | Menetelmä lääkeaineina käyttökelpoisten imidatso/4,5-b/kinolinyylioksialkaanihappoamidien valmistamiseksi | |
DE69130412T2 (de) | Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung | |
AU2014267974B2 (en) | Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof | |
JPH0687856A (ja) | 8‐クロロ‐11‐〔1‐〔(5‐メチル‐3‐ピリジル)メチル〕‐4‐ピペリジリデン〕‐6,11‐ジヒドロ‐5H‐ベンゾ〔5,6〕シクロヘプタ〔1,2‐b〕ピリジン | |
EP0482939A1 (en) | Isoquinolinone derivative | |
PL188908B1 (pl) | Nowe pochodne benzimidazolu i ich zastosowanie dowytwarzania leków do leczenia stanów alergicznych | |
JPS63119464A (ja) | 新規置換ジヒドロピリジン誘導体、その製造方法、およびその誘導体からなる薬剤、その製造方法 | |
KR20100031610A (ko) | 아데노신 A3 수용체 리간드로서의 트리아졸로[1,5-a]퀴놀린 | |
ES2850023T3 (es) | Compuesto de anillo heterocíclico nítrico de seis miembros sustituido con amino y preparación y uso del mismo | |
JPH05140162A (ja) | 精神的疾病を治療するための製薬学的調剤、ピリダジンジオン化合物および該化合物の製造法 | |
DE69518647T2 (de) | Pyridyl-imidazol-derivate und verfahren zu ihrer herstellung | |
US4446323A (en) | Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline derivatives | |
CS226901B1 (en) | Thiazoloisoquinoline derivatives | |
JP3269658B2 (ja) | フェノール誘導体 | |
US4716166A (en) | Histamine H1 antagonists | |
US4600758A (en) | Isoindole derivatives | |
US20010046991A1 (en) | Derivatives of quinoline as alpha-2 antagonists | |
MXPA98002028A (en) | Quinolein-2 (1h) -ona derivatives as seroton antagonists | |
EP0405784A1 (en) | Novel benzisoquinoline derivatives | |
TW449592B (en) | 2-(1H)-Quinolone derivatives, their preparation and their use in therapy | |
JPH07620B2 (ja) | 縮合イミダゾピリジン誘導体 | |
JP2003516990A (ja) | 経口で活性のあるエラスターゼ阻害剤としてのサッカリン誘導体 | |
JPH0138109B2 (no) | ||
JPH07316162A (ja) | 三環式化合物 |